An International Non-interventional Cohort Study to Evaluate the Safety of Treatment With Levemir (Insulin Detemir) in Pregnant Women With Diabetes Mellitus
Phase of Trial: Phase IV
Latest Information Update: 16 Oct 2019
Price : $35 *
At a glance
- Drugs Insulin detemir (Primary) ; Insulins
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Novo Nordisk
- 14 Oct 2019 Status changed from active, no longer recruiting to completed.
- 22 Apr 2019 Planned End Date changed from 31 Dec 2019 to 30 Sep 2019.
- 22 Apr 2019 Planned primary completion date changed from 31 Dec 2019 to 30 Sep 2019.